SK78994A3 - Optic hypotensive agent and method of its preparation - Google Patents
Optic hypotensive agent and method of its preparation Download PDFInfo
- Publication number
- SK78994A3 SK78994A3 SK789-94A SK78994A SK78994A3 SK 78994 A3 SK78994 A3 SK 78994A3 SK 78994 A SK78994 A SK 78994A SK 78994 A3 SK78994 A3 SK 78994A3
- Authority
- SK
- Slovakia
- Prior art keywords
- group
- compound
- hydrogen
- methyl
- agent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4245—Oxadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/433—Thidiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP16484793 | 1993-07-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK78994A3 true SK78994A3 (en) | 1995-07-11 |
Family
ID=15801055
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK789-94A SK78994A3 (en) | 1993-07-02 | 1994-06-30 | Optic hypotensive agent and method of its preparation |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US5639773A (no) |
| EP (1) | EP0631780A1 (no) |
| KR (1) | KR950002760A (no) |
| CN (1) | CN1105239A (no) |
| AU (2) | AU7083394A (no) |
| BR (1) | BR9402618A (no) |
| CA (1) | CA2127202A1 (no) |
| CZ (1) | CZ154994A3 (no) |
| FI (1) | FI943182A (no) |
| HU (1) | HUT69713A (no) |
| NO (1) | NO942472L (no) |
| PL (1) | PL304080A1 (no) |
| SK (1) | SK78994A3 (no) |
| WO (1) | WO1995001176A1 (no) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ282485A (en) * | 1994-03-16 | 1997-06-24 | Sankyo Co | Treatment of ocular hypertension using imidazole derivatives |
| WO2000066161A1 (fr) | 1999-04-28 | 2000-11-09 | Takeda Chemical Industries, Ltd. | Preventifs / remedes / inhibiteurs de progression pour retinopathie simplex ou retinopathie preproliferante |
| WO2000076543A1 (fr) * | 1999-06-11 | 2000-12-21 | Sankyo Company, Limited | Composition permettant de reduire la tension oculaire et destinee a l'administration topique |
| WO2001005428A1 (fr) * | 1999-07-21 | 2001-01-25 | Takeda Chemical Industries, Ltd. | Methodes preventives contre la recurrence d'une insuffisance cerebrovasculaire, et agents destines a ameliorer des troubles causes par une insuffisance cerebrovasculaire et a inhiber leur evolution |
| TWI290470B (en) | 1999-12-01 | 2007-12-01 | Sankyo Co | The composition for treating glaucoma |
| AU2002218527A1 (en) * | 2000-12-05 | 2002-06-18 | Sankyo Company Limited | Ocular tension-lowering compositions for topical administration |
| US7232828B2 (en) * | 2002-08-10 | 2007-06-19 | Bethesda Pharmaceuticals, Inc. | PPAR Ligands that do not cause fluid retention, edema or congestive heart failure |
| US20090042962A1 (en) * | 2005-04-21 | 2009-02-12 | Santen Pharmaceutical Co., Ltd. | Therapeutic Agent for Keratoconjunctival Disorder |
| JP5283632B2 (ja) * | 2007-03-28 | 2013-09-04 | 武田薬品工業株式会社 | ベンズイミダゾール−７−カルボキシレート誘導体およびｐＨ調整剤を含有する固形医薬組成物 |
| ME02663B (me) | 2010-10-06 | 2017-06-20 | Glaxosmithkline Llc | Derivati benzimidazola kao inhibitori pi3 kinaze |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3928177A1 (de) * | 1989-04-08 | 1991-02-28 | Thomae Gmbh Dr K | Benzimidazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
| EP0400835A1 (en) * | 1989-05-15 | 1990-12-05 | Merck & Co. Inc. | Substituted benzimidazoles as angiotensin II antagonists |
| EP0411507B1 (en) * | 1989-08-02 | 1994-10-26 | Takeda Chemical Industries, Ltd. | Pyrazole derivatives, their production and use |
| US5250554A (en) * | 1989-10-24 | 1993-10-05 | Takeda Chemical Industries, Ltd. | Benzimidazole derivatives useful as angiotensin II inhibitors |
| IL95975A (en) * | 1989-10-24 | 1997-06-10 | Takeda Chemical Industries Ltd | N-benzyl- 2-alkylbenzimidazole derivatives, their production and pharmaceutical compositions containing them |
| EP0430300A3 (en) * | 1989-12-01 | 1992-03-25 | Takeda Chemical Industries, Ltd. | Xanthine derivatives, their production and use |
| EP0434038A1 (en) * | 1989-12-22 | 1991-06-26 | Takeda Chemical Industries, Ltd. | Fused imidazole derivatives, their production and use |
| US5162326A (en) * | 1990-02-15 | 1992-11-10 | Takeda Chemical Industries, Ltd. | Pyrimidinedione derivatives, their production and use |
| US5284661A (en) * | 1990-02-22 | 1994-02-08 | Takeda Chemical Industries, Ltd. | Fused thiophene derivatives, their production and use |
| CA2037630C (en) * | 1990-03-07 | 2001-07-03 | Akira Morimoto | Nitrogen-containing heterocylic compounds, their production and use |
| WO1991015206A1 (en) * | 1990-04-05 | 1991-10-17 | E.I. Du Pont De Nemours And Company | Treatment of glaucoma and ocular hypertension with imidazole angiotensin-ii receptor antagonists |
| WO1991016313A1 (en) * | 1990-04-13 | 1991-10-31 | Smithkline Beecham Corporation | Substituted benzimidazoles |
| US5196444A (en) * | 1990-04-27 | 1993-03-23 | Takeda Chemical Industries, Ltd. | 1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof |
| US5102903A (en) * | 1990-05-10 | 1992-04-07 | E. I. Du Pont De Nemours And Company | Treatment of glaucoma and ocular hypertension with pyrazole, pyrrole and triazole angiotensin-II receptor antagonists |
| AU636066B2 (en) * | 1990-10-30 | 1993-04-08 | Takeda Chemical Industries Ltd. | Thienoimidazole derivatives, their production and use |
| TW274551B (no) * | 1991-04-16 | 1996-04-21 | Takeda Pharm Industry Co Ltd | |
| IL102183A (en) * | 1991-06-27 | 1999-11-30 | Takeda Chemical Industries Ltd | The heterocyclic compounds are converted into biphenyl groups, their production and the pharmaceutical compositions containing them |
| DE69319391T2 (de) * | 1992-09-14 | 1998-10-29 | Takeda Chemical Industries Ltd | 1,2,4-Oxadiazolyl oder 1,2,4-Thiadiazolyl-Derivate als Angiotensin II Antagonisten |
| DE69330593T2 (de) * | 1992-12-22 | 2002-06-27 | Takeda Chemical Industries, Ltd. | Heterocyclische Verbindungen mit Angiotensin-II-antagonistischer Wirkung und ihre Anwendung |
-
1994
- 1994-06-23 CZ CZ941549A patent/CZ154994A3/cs unknown
- 1994-06-30 KR KR1019940015606A patent/KR950002760A/ko not_active Application Discontinuation
- 1994-06-30 CA CA002127202A patent/CA2127202A1/en not_active Abandoned
- 1994-06-30 SK SK789-94A patent/SK78994A3/sk unknown
- 1994-06-30 NO NO942472A patent/NO942472L/no unknown
- 1994-07-01 EP EP94110283A patent/EP0631780A1/en not_active Ceased
- 1994-07-01 AU AU70833/94A patent/AU7083394A/en not_active Abandoned
- 1994-07-01 FI FI943182A patent/FI943182A/fi not_active Application Discontinuation
- 1994-07-01 PL PL94304080A patent/PL304080A1/xx unknown
- 1994-07-01 HU HU9402006A patent/HUT69713A/hu unknown
- 1994-07-01 AU AU66146/94A patent/AU6614694A/en not_active Abandoned
- 1994-07-01 WO PCT/JP1994/001072 patent/WO1995001176A1/en unknown
- 1994-07-01 US US08/269,675 patent/US5639773A/en not_active Expired - Fee Related
- 1994-07-02 CN CN94108931A patent/CN1105239A/zh active Pending
- 1994-07-04 BR BR9402618A patent/BR9402618A/pt not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0631780A1 (en) | 1995-01-04 |
| KR950002760A (ko) | 1995-02-16 |
| PL304080A1 (en) | 1995-01-09 |
| HUT69713A (en) | 1995-09-28 |
| HU9402006D0 (en) | 1994-09-28 |
| BR9402618A (pt) | 1995-04-04 |
| NO942472L (no) | 1995-01-03 |
| FI943182A (fi) | 1995-04-04 |
| CA2127202A1 (en) | 1995-01-03 |
| CZ154994A3 (en) | 1995-09-13 |
| FI943182A0 (fi) | 1994-07-01 |
| WO1995001176A1 (en) | 1995-01-12 |
| US5639773A (en) | 1997-06-17 |
| NO942472D0 (no) | 1994-06-30 |
| CN1105239A (zh) | 1995-07-19 |
| AU6614694A (en) | 1995-01-12 |
| AU7083394A (en) | 1995-01-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU713277B2 (en) | Pharmaceutical combination containing a compound having angiotensin II and antagonistic activity | |
| US20060189669A1 (en) | Pharmaceutical composition for preventing, treating or development-inhibiting simple retinopathy and preproliferative retinopathy | |
| US20100120800A1 (en) | Agent for preventing recurrence of cerebrovascular disorder and agent for ameliorating troubles following cerebrovascular disorder and inhibiting progress thereof | |
| JP2930252B2 (ja) | アンジオテンシン−▲ｉｉ▼受容体拮抗剤およびカルシウムチャンネルブロッカーの新規組成物 | |
| SK11902000A3 (sk) | Prostriedok s predĺženým uvoľňovaním pre antagonistu angiotenzínu ii, jeho príprava a použitie | |
| SK78994A3 (en) | Optic hypotensive agent and method of its preparation | |
| JP3057471B2 (ja) | アンジオテンシンｉｉ介在性諸疾患の予防または治療剤 | |
| JPH0867674A (ja) | 眼圧降下剤 | |
| JP2000159671A (ja) | 血管新生阻害剤 | |
| EP3900722A1 (en) | Combination of finerenone and pecavaptan for the treatment and/or prevention of cardiovascular and/or renal diseases | |
| JP4276768B2 (ja) | 単純網膜症・前増殖網膜症の予防・治療・進展抑制剤 | |
| EP1579872B1 (en) | Body weight gain inhibitor | |
| JP2002212101A (ja) | 歯肉肥厚抑制剤 | |
| EP1115399A1 (fr) | Utilisation d'une composition pharmaceutique contenant, en association, un antagoniste des recepteurs at1 de l'angiotensine ii et l'indomethacine pour la fabrication d'un medicament pour traiter les glomerulonephrites chroniques |